Harbour Investments, Inc. Dyne Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$11.89 - $16.07 $107 - $144	-9 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $78 - $107	-5 Reduced 35.71%	9 $0
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $15 - $22	-1 Reduced 6.67%	14 $0
Q1 2021 Aug 17, 2021	BUY	$14.0 - $29.3 $196 - $410	14 Added 1400.0%	15 $0
Q1 2021 May 12, 2021	BUY	$14.0 - $29.3 $14 - $29	1 New	1 $0

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $701M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.